Intrathecal Versus Intravenous Dexmeditomedine in Transurethral Resection of the Prostate

NCT04618965 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Dexmedetomidine
Transurethral Resection of Prostate
Intravenous
Intrathecal

Interventions

DRUG: control group
DRUG: Intrathecal dexmedetomidine
DRUG: Intravenous dexmedetomidine

Sponsor

Tanta University